Institutional Fund
Bios Capital Management, LP
Fort Worth, TXCIK 18138455 filings on record
Portfolio Value
$52.87M
Q1 2026
Holdings
6
Reported positions
New Buys
0
Opened this quarter
QoQ Change
-36.0%
from $82.62M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Actuate Therapeutics Inc52.1%
- Opus Genetics Inc31.7%
- Cognition Therapeutics Inc8.6%
- Rein Therapeutics Inc4.9%
- Lantern Pharma Inc2.2%
- In8bio Inc0.5%
Portfolio Holdings
6 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Actuate Therapeutics Inc | 10.05M | $27.54M | 52.1% | 0 | Held |
| 2 | Opus Genetics Inc | 3.68M | $16.76M | 31.7% | 0 | Held |
| 3 | Cognition Therapeutics Inc | 6.00M | $4.56M | 8.6% | 0 | Held |
| 4 | Rein Therapeutics Inc | 1.98M | $2.58M | 4.9% | +291.6K | Added |
| 5 | Lantern Pharma Inc | 864.4K | $1.18M | 2.2% | −145.1K | Reduced |
| 6 | In8bio Inc | 167.8K | $248.4K | 0.5% | −85.6K | Reduced |